Journal article · 2017 · Open access

Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study

For the PROMPT Study Group, Emma K. Dures, Sarah Hewlett, Jane Lord, Clive Bowen, Neil John McHugh, William L. Tillett

Patient, 10(4), 455–462 · Published 22 February 2017 · DOI 10.1007/s40271-017-0221-4

Open PDFView at the publisherCite this paper

In brief

“Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study” is a 2017 journal article by For the PROMPT Study Group and 6 co-authors, published in Patient. OpenAlex counts 70 citations as of 22 November 2026, which puts it in the top 6% of works published in 2017 by citations. It is open access under a CC BY licence: the full text is free to read at Patient.

Citations
70
Most cited in
2020 (11)
Field-weighted impact
5.14
References
29
Authors
7

Abstract

BACKGROUND: Psoriatic arthritis (PsA) is a variable and complex inflammatory condition. Symptoms can compromise physical function, reduce quality of life, and accrue significant health costs. Commonly used patient-reported outcomes largely reflect the professionals' perspective, however it is not known whether they capture what is important to patients. OBJECTIVE: The aim of our study was to identify treatment outcomes important to patients with PsA. METHODS: Eight focus groups that were audio recorded, transcribed, anonymised and analysed using inductive thematic analysis were conducted at five hospital sites. The full data set was analysed by the lead researcher, and subsets analysed by three team members (including patient partners). RESULTS: Overall, 41 patients sampled for a range of phenotypes and domains of disease activity participated in the study: 20 males; mean age 58 years (range 28-75, standard deviation [SD] 11.4); mean disease duration 9 years (range 0.5-39, SD 8.3); and mean Health Assessment Questionnaire score of 1 (range 0.0-2.5, SD 0.7). Over 60 outcomes were identified and grouped into four themes: (i) symptom alleviation (e.g. pain, fatigue, itchy skin, swelling, and reducing variability); (ii) reduction of disease impact (e.g. tiredness and pain, mobility and dexterity, deteriorating physical fitness, negative emotional responses, and strained relationships and social interactions); (iii) improved prognosis (e.g. slowing down disease progression, maintaining independence, and enhancing quality of life); and (iv) minimisation of treatment harm and burden (e.g. nausea, long-term effects, and administration and monitoring of treatments). CONCLUSIONS: Outcomes from treatments that are important to patients, which relate to impacts from PsA and its treatment that range beyond those outcomes commonly measured, were identified. These patient perspectives need to be considered when evaluating treatments.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

For the PROMPT Study Group, Dures, E. K., Hewlett, S., Lord, J., Bowen, C., McHugh, N. J., & Tillett, W. L. (2017). Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study. Patient, 10(4), 455–462. https://doi.org/10.1007/s40271-017-0221-4

MLA 9

For the PROMPT Study Group, et al. “Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study.” Patient, vol. 10, no. 4, 2017, pp. 455–462. https://doi.org/10.1007/s40271-017-0221-4.

Chicago

For the PROMPT Study Group, Emma K. Dures, Sarah Hewlett, Jane Lord, Clive Bowen, Neil John McHugh, and William L. Tillett. 2017. “Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study.” Patient 10 (4): 455–462. https://doi.org/10.1007/s40271-017-0221-4.

Harvard

For the PROMPT Study Group et al. (2017) ‘Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study’, Patient, 10(4), pp. 455–462. doi:10.1007/s40271-017-0221-4.

IEEE

For the PROMPT Study Group et al., “Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study,” Patient, vol. 10, no. 4, pp. 455–462, 2017, doi: 10.1007/s40271-017-0221-4.

BibTeX

@article{forthepromptstudygroup2017important,
  title     = {{Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study}},
  author    = {For the PROMPT Study Group and Dures, Emma K. and Hewlett, Sarah and Lord, Jane and Bowen, Clive and McHugh, Neil John and Tillett, William L.},
  journal   = {Patient},
  year      = {2017},
  volume    = {10},
  number    = {4},
  pages     = {455--462},
  doi       = {10.1007/s40271-017-0221-4},
  url       = {https://doi.org/10.1007/s40271-017-0221-4}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201733
201888
201955
20201111
20211010
20221111
202399
202422
202555
202666

Its field-weighted citation impact is 5.14: it has been cited 5.14 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments

  • psoriatic arthritis
  • patient-reported outcomes
  • treatment outcomes
  • patient perspectives
  • symptom relief
  • disease impact
  • quality of life
  • treatment burden

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

For the PROMPT Study Group, Dures, E. K., Hewlett, S., Lord, J., Bowen, C., McHugh, N. J., & Tillett, W. L. (2017). Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study. Patient, 10(4), 455–462. https://doi.org/10.1007/s40271-017-0221-4

How many times has this paper been cited?

70 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Patient: sign in and open the PDF from this page.

Who wrote this paper?

For the PROMPT Study Group, Emma K. Dures, Sarah Hewlett, Jane Lord, Clive Bowen, Neil John McHugh, William L. Tillett.

What is the DOI of this paper?

10.1007/s40271-017-0221-4, permanently at https://doi.org/10.1007/s40271-017-0221-4. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.